Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
151 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Investigational Site Number 032002
Ciudad Autonoma de Bs.As, Argentina
- Investigational Site Number 032003
Corrientes, Argentina
- Investigational Site Number 032004
San Miguel de Tucumán, Argentina
- Investigational Site Number 036012
Adelaide, Australia
- Investigational Site Number 036006
Auchenflower, Australia
- Investigational Site Number 036004
Bedford Park, Australia
- Investigational Site Number 036014
Camperdown, Australia
- Investigational Site Number 036013
Garran, Australia
- Investigational Site Number 036010
Gosford, Australia
- Investigational Site Number 036005
Herston, Australia
- Investigational Site Number 036008
Nedlands, Australia
- Investigational Site Number 036009
New Lambton, Australia
- Investigational Site Number 036007
Perth, Australia
- Investigational Site Number 036003
Woolloongabba, Australia
- Investigational Site Number 056005
Aalst, Belgium
- Investigational Site Number 056007
Bruges, Belgium
- Investigational Site Number 056001
Brussels, Belgium
- Investigational Site Number 056002
Gilly, Belgium
- Investigational Site Number 056004
Hasselt, Belgium
- Investigational Site Number 056003
Roeselare, Belgium
- Investigational Site Number 124009
Calgary, Canada
- Investigational Site Number 124010
Hamilton, Canada
- Investigational Site Number 124004
London, Canada
- Investigational Site Number 124001
Montreal, Canada
- Investigational Site Number 124008
Montreal, Canada
- Investigational Site Number 124005
Ste-Foy, Canada
- Investigational Site Number 124002
Toronto, Canada
- Investigational Site Number 124006
Vancouver, Canada
- Investigational Site Number 124007
Victoria, Canada
- Investigational Site Number 152001
Santiago, Chile
- Investigational Site Number 203004
Brno, Czechia
- Investigational Site Number 203005
Hradec Králové, Czechia
- Investigational Site Number 203001
Liberec, Czechia
- Investigational Site Number 203003
Olomouc, Czechia
- Investigational Site Number 203006
Prague, Czechia
- Investigational Site Number 203002
České Budějovice, Czechia
- Investigational Site Number 208002
Aarhus, Denmark
- Investigational Site Number 208004
Hellerup, Denmark
- Investigational Site Number 208005
København Ø, Denmark
- Investigational Site Number 208001
Odense C, Denmark
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2009
- Primary completion
- 31 May 2011
- Completion
- 31 May 2011
- Last update posted
- 30 May 2016
- Registered enrollment
- 486
- Registry id
- NCT00993382
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.